|
Session 125-Poster Abstracts
Acute Hepatitis C Infection
Wednesday, 2-4 pm; Poster Hall |
639
 |
Kinetically Guided PEG Alfa-2a and RBV Therapy for HIV+ Adults with Acute HCV Infection
Bradley Hare*1, K Marks2, A Luetkemeyer1, E Charlebois1, M Glesby2, A Talal2, D V Havlir1, and M Peters1
1Univ of California, San Francisco, US and 2Weill Cornell Med Coll, New York, NY, US |
640
|
Use of Week 4 HCV RNA after Acute HCV Infection to Predict Chronic HCV Infection
Martin Vogel*1, E Page2, G Matthews3, M Guiguet4, S Dominguez5, G Dore3, C Katlama4,5, M Nelson2, S Bhagani6, J Rockstroh1, and the NEAT Study Group
1Univ of Bonn, Germany; 2Chelsea and Westminster Hosp, London, UK; 3Natl Ctr in HIV Epi and Clin Res, Sydney, Australia; 4INSERM U943 and UMRS943, Univ Paris 6 and Pierre and Marie Curie, France; 5Hosp Pitie-Salpetriere, Paris, France; and 6Royal Free Hosp, London, UK |
| 641 |
Treatment Outcome of Acute HCV Infection in HIV-infected MSM: Effect of Treatment Length
Femke Lambers*1, G van den Berk2, J van der Meer3, I Spijkerman2, R Molenkamp3, R Coutinho1,3,4, M Prins1,3, K Brinkman2, and J Schinkel3
1Publ Hlth Svc, Amsterdam, The Netherlands; 2Onze Lieve Vrouwe Gasthius, Amsterdam, The Netherlands; 3Academic Med Ctr, Amsterdam, The Netherlands; and 4Natl Inst of Publ Hlth and the Environment, Bilthoven, The Netherlands |
642
|
Liver Fibrosis Progression after Acute HCV Infection in HIV+ Individuals
Martin Vogel*1, E Page2, P Holmes2, J Wilkinson2, C Schwarze-Zander1, S Mauss3, A Baumgarten4, J-C Wasmuth1, M Nelson2, J Rockstroh1, and the NEAT Study Group
1Univ of Bonn, Germany; 2Chelsea and Westminster Hosp, London, UK; 3Practice Mauss/Schmutz/Hegener/Athmann, Düsseldorf, Germany; and 4Practice Dupke/Baumgarten/Carganico, Berlin, Germany |
|
